Relationship between angiotensin-converting enzyme gene polymorphism (insertion/deletion) and the clinical condition of sepsis in Turkish children;Türk çocuklarında anjiyotensin konverting enzim gen polimorfizmi (insersiyon/delesyon) ve sepsis klinik durumları arasındaki ilişki

Turkiye Klinikleri Journal of Medical Sciences

Volumn 30, Issue 2, 2010, Pages 591-597

  Çelik, Ümit ^a   Yildizdaş, Dinçer ^a   Çelik, Tamer ^a   Alhan, Emre ^a   Atila, Gülen ^a   Tepe, Tugay ^a   Sertdemir, Yaşar ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Child; Genetic; Multiple organ failure; Polymorphism; Sepsis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CAUSAL ATTRIBUTION; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOCARDITIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESPIRATORY DISTRESS; RISK FACTOR; SEPSIS; TURKEY (REPUBLIC); URINARY TRACT INFECTION; WOUND INFECTION;

EID: 77952898806     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: 10.5336/medsci.2008-8223     Document Type: Article

References (32)

1. Yildizdas D. [Treatment of sepsis and septic shock in children]. Turkiye Klinikleri J Pediatr Sci 2005;1(1):85-95.
2. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348(2):138-50.
3. Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006;34(4):1001-6.
4. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86(4):1343-6.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359(6396): 641-4.
6. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90(6):2622-8.
7. Ozen S, Alikasifoglu M, Saatci U, Bakkaloglu A, Besbas N, Kara N, et al. Implications of certain genetic polymorphisms in scarring in vesicoureteric reflux: importance of ACE polymorphism. Am J Kidney Dis 1999;34(1):140-5.
8. Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, Hart A, et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002; 165(8):1103-6.
9. Sivasli E, Yurdakök M, Babaoglu E, Karabulut H, Yigit S, Babaoglu M, et al. ACE gene deletion/deletion polymorphism may be a protective factor for respiratory distress in preterm infants. Turk J Pediatr 2007;49(1):69-74.
10. Wang B, Jin F, Yang Z, Lu Z, Kan R, Li S, et al. The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease. J Mol Neurosci 2006;30(3):267-71.
11. Yanamandra K, Loggins J, Baier RJ. The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. BMC Pediatr 2004;4(1):26.
12. John Baier R, Loggins J, Yanamandra K. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. J Perinatol 2005;25(3):205-9.
13. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6(1):2-8.
14. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant out-comes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994;20(3):225-32.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
16. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184(1):9-15.
17. Lazarus DS, Aschoff J, Fanburg BL, Lanzillo JJ. Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines. Biochim Biophys Acta 1994;1226(1):12-8.
18. Watanabe K, Lam G, Keresztes RS, Jaffe EA. Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J Cell Physiol 1992;150(2):433-9.
19. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med 1999;159(4 Pt 1):1342-50.
20. Morrison CD, Papp AC, Hejmanowski AQ, Addis VM, Prior TW. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 2001;32(5):521-8.
21. Furuya K, Yamaguchi E, Itoh A, Hizawa N, Ohnuma N, Kojima J, et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 1996;51(8):777-80.
22. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999;13(4):723-6.
23. Yokoyama T, Sekiguchi K, Tanaka T, Tomaru K, Arai M, Suzuki T, et al. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 1999;276(6 Pt 2):H1968-76.
24. Dimmeler S, Rippmann V, Weiland U, Haen-deler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997;81(6):970-6.
25. Wang R, Alam G, Zagariya A, Gidea C, Pinillos H, Lalude O, et al. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J Cell Phys-iol 2000;185(2):253-9.
26. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999;276(5 Pt 1):L885-9.
27. Maclean AA, Liu M, Fischer S, Suga M, Keshavjee S. Targeting the angiotensin system in posttransplant airway obliteration: the antifibrotic effect of angiotensin converting enzyme inhibition. Am J Respir Crit Care Med 2000;162(1):310-5.
28. Marshall RP, Gohlke P, Chambers RC, How-ell DC, Bottoms SE, Unger T, et al. An-giotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004;286(1):L156-64.
29. Fourrier F, Chopin C, Wallaert B, Mazurier C, Mangalaboyi J, Durocher A. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 1985;87(2):191-5.
30. Marshall RP, Webb S, Bellingan GJ, Mont-gomery HE, Chaudhari B, McAnulty RJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166(5):646-50.
31. Chan KC, Tang NL, Hui DS, Chung GT, Wu AK, Chim SS, et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 2005; 5(1):26.
32. Villar J, Flores C, Pérez-Méndez L, Maca-Meyer N, Espinosa E, Blanco J, et al. Angiotensin-converting enzyme insertion/ deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008;34(3):488-95.